Evidence map›Paper›PMID 37217165›Full record

SynthesisThe American journal of tropical medicine and hygiene2023

Prevalence of Chronic Hepatitis B Virus Infection in Sierra Leone, 1997-2022: A Systematic Review and Meta-Analysis.

George A Yendewa, Gi-Ming Wang, Peter B James, Samuel P E Massaquoi, Sahr A Yendewa, Manal Ghazawi, Lawrence S Babawo, Ponsiano Ocama, James B W Russell, Gibrilla F Deen and 5 more

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The American journal of tropical medicine and hygiene, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 5 countries.

George A YendewaDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Gi-Ming WangCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Peter B JamesFaculty of Health, Southern Cross University, Lismore, Australia.
Samuel P E MassaquoiMinistry of Health and Sanitation, Freetown, Sierra Leone.
Sahr A YendewaMinistry of Health and Sanitation, Freetown, Sierra Leone.
Manal GhazawiKnowHep Foundation, Freetown, Sierra Leone.
Lawrence S BabawoDepartment of Nursing, School of Community Health Sciences, Njala University, Bo, Sierra Leone.
Ponsiano OcamaDepartment of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
James B W RussellMinistry of Health and Sanitation, Freetown, Sierra Leone.
Gibrilla F DeenMinistry of Health and Sanitation, Freetown, Sierra Leone.
Foday SahrMinistry of Health and Sanitation, Freetown, Sierra Leone.
Mustapha KabbaMinistry of Health and Sanitation, Freetown, Sierra Leone.
Curtis TatsuokaCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Sulaiman LakohMinistry of Health and Sanitation, Freetown, Sierra Leone.
Robert A SalataDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Ministry of Health and Sanitation · SLCase Western Reserve University · USUniversity of Sierra Leone · SLChildren’s Foundation · GBJohns Hopkins University · USMakerere University · UGNjala University · SLSouthern Cross University · AUUniversity School · US

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
NIAID NIH HHS UM1 AI068636
6 · The paper itself

Abstract

Hepatitis B virus (HBV) infection is a major public health problem in Sierra Leone, yet reliable estimates of cases are lacking. This study aimed to provide an estimate of the national prevalence of chronic HBV infection in the general population and select groups in Sierra Leone. We used the electronic databases PubMed/MEDLINE, Embase, Scopus, ScienceDirect, Web of Science, Google Scholar, and African Journals Online to systematically review articles reporting hepatitis B infection surface antigen seroprevalence estimates in Sierra Leone during 1997-2022. We estimated pooled HBV seroprevalence rates and assessed potential sources of heterogeneity. Of 546 publications screened, 22 studies with a total sample size of 107,186 people were included in the systematic review and meta-analysis. The pooled prevalence of chronic HBV infection was 13.0% (95% CI, 10.0-16.0) (I2 = 99%; Pheterogeneity < 0.01). During the study period, the HBV prevalence rates were as follows: 17.9% (95% CI, 6.7-39.8) before 2015, 13.3% (95% CI, 10.4-16.9) during 2015-2019, and 10.7% (95% CI, 7.5-14.9) during 2020-2022. The use of the 2020-2022 HBV prevalence estimates corresponded to 870,000 cases of chronic HBV infection (uncertainty interval, 610,000-1,213,000), or approximately one in nine people. The highest HBV seroprevalence estimates were among adolescents aged 10-17 years (17.0%; 95% CI, 8.8-30.5), Ebola survivors (36.8%; 95% CI, 26.2-48.8), people living with HIV (15.9%; 95% CI, 10.6-23.0), and those in the Northern Province (19.0%; 95% CI, 6.4-44.7) and Southern Province (19.7%; 95% CI, 10.9-32.8) regions. These findings may help inform national HBV program implementation in Sierra Leone.

Indexed as

Hepatitis BHepatitis B, ChronicAdolescentHepatitis B Surface AntigensHepatitis B virusHumansPrevalenceSeroepidemiologic StudiesSierra LeoneHepatitis B Surface Antigens

Identifiers

PMID37217165
PMCPMC10323991
OpenAlexW4377237861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.